跳至主要内容
临床试验/JPRN-jRCT2080224916
JPRN-jRCT2080224916已完成3 期

A Phase 3 Study in Patients with Chronic Idiopathic Thrombocytopenic Purpura in R788

Kissei Pharmaceutical Co., Ltd.0 个研究点目标入组 24 人开始时间: 2019年10月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients diagnosed with ITP at least 6 months before acquisition of consent
  • - Patients with a platelet count average of < 30000/uL during screening period and with each platelet count < 35000/uL
  • - Patients who have used and failed at least 1 of the typical ITP medications before informed consent

排除标准

  • - Patients with thrombocytopenia associated with other diseases
  • - Patients with autoimmune hemolytic anemia
  • - Patients with poor blood pressure control
  • - Patients with or with a history of a history of coagulopathy

研究者

相似试验